The Division of Hematology and Oncology at the University of California San Francisco offers specialized training for physicians interested in adult blood and marrow transplantation (BMT) and cancer immunotherapies including cellular therapies (CT).
This intensive one-year fellowship is designed to prepare physicians for academic careers focusing on management of hematologic malignancies using transplantation and immune effector cell (IEC) therapy modalities, including CAR-T cells, NK cells, and cell vaccines. Our transplant and cellular therapy program is very active and we have 16 departmental faculty members capable of serving as clinical preceptors and research mentors. We have active clinical and translational research programs focused on hematopoiesis, leukemia, lymphoma, multiple myeloma, myeloproliferative neoplasms and immunology. Special interests include the development of novel conditioning regimens for transplant, investigating new treatments for graft vs. host disease, development of novel IEC therapies and cell vaccines, and management of transplant, IEC and immunotherapy complications.
For more information about the program, kindly visithttps://ucsfhealthhemonc.ucsf....
Candidates must be board certified in Internal Medicine and be board eligible or board certified graduates of an accredited US Hematology and/or Medical Oncology fellowship program.
Due to funding restrictions, applicants must be U.S. Citizens, U.S. Permanent Residents or have a J1 Visa (H1B Visas are not accepted). Applicants must be eligible for a California Medical License.
We require the following supporting documents to be submitted before your application will be considered:
UCSF – Hematology/Oncology
E-Mail: [email protected]
Jun 02, 2021
San Francisco, California